Limitations and strengths
DISEASE, SECONDARY, PATHOLOGY, LONG COVID
Our study has some limitations. First, although the secondary data analysis of RCTs are a good starting point to know the baseline situations of some investigations [Regarding the strengths, research on the Long COVID disease is scaled up and, particularly, the impact on the quality of life of those affected. For this reason, this study adds to the existing studies that show the great affectation that these patients suffer in their quality of life, as well as the associated factors. In addition, all the participants are usually attended in PHC consultations, so our results are representative of a PHC clinical population with this pathology.